The Trump administration is moving to help Medicare patients access more accurate tests for cancer.
The Centers for Medicare and Medicaid Services will now cover Medicare diagnostic lab tests that use DNA testing to determine the best treatment for patients with advanced cancer like patients with stage IV or metastatic cancers.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
